More Articles

Clinical

Broadening participation in clinical trials: A win for all

Joseph Constance, (Jan 6, 2021)

Broader and deeper outreach, along with RWE, are some of the methods pharma is using to widen trials participation
Commercial

Blended and augmented: Reimagining the role of the rep

Andrew Stone, (Dec 18, 2020)

The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement
Commercial

Uncorking the compliance bottlenecks in digital

Andrew Stone, (Dec 17, 2020)

The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology
Clinical

Maimah Karmo: Surviving, fighting, winning

Andrew Stone, (Nov 26, 2020)

The Tigerlily Foundation President and Founder is more hopeful than ever that she can help pharma give Black women the representation they deserve in trials and beyond
Medical

COVID-19: A data challenge and a catalyst for new insights

Andrew Stone, (Nov 24, 2020)

The healthcare ecosystem has demonstrated its ability to share data to uncover new insights this year but there is more to be done, says Nigel Hughes, scientific director at Epidemiology, Janssen R&D
Patients and Medical

Building a health equity culture

Andrew Stone, (Nov 17, 2020)

Health inequities, often a legacy of racism, lie heavy on the healthcare sector in the US and beyond. Fixing the problem will require long-term effort on multiple fronts
Commercial

Creating a holistic customer experience

Rhonda Siddall, (Nov 17, 2020)

Finding solutions to unmet customer needs means harnessing the combined power of medical and marketing skills – and creating a culture to match
Multichannel

Reimagining the life sciences beyond COVID-19

Blair Gottscho, (Nov 17, 2020)

A new report from Reuters Events Pharma and EY reveals the impacts on the life sciences sector and analyses the road ahead
Clinical

Automation is key in cell and gene therapy manufacturing

Andrew Stone, (Oct 30, 2020)

Although the list of cell and gene therapies is growing, prices remain high. Now developers are working on a road map to streamline production and drop costs
Multichannel

How sustainable is remote health at scale?

Nicola Davies, (Oct 28, 2020)

Remote health has proved its worth to the entire healthcare sector but sustaining and scaling it requires work from every stakeholder

Pages